WHO ICTRP trial
The pivotal bioequivalence study comparing the test product to the reference…
CTIS2025-523325-18-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2025-523325-18-00 |
|---|---|
| Public title | The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment of schizophrenia in adults patients. |
| Scientific title | - 1053/25 |
| Primary sponsor | Adamed Pharma S.A. |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Czechia |
| Conditions | Bioequivalence study under fasting conditions MedDRA version: 20.0Level: PTClassification code: 10039626Term: Schizophrenia Class: 100000004873;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03] |
| Registration date | Sep 9, 2025 |
| Target size | 36 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: